科指反覆回升1.5% 平安好醫生、理想及聯想升3%-6%
市場繼續擔心美國通脹壓力持續,或致聯儲局再度加大加息幅度或延長加息週期,美國科技股持續受壓,拖累納指兩連吐。此外,反映中概股表現金龍中國指數上週五回吐3.1%。然而,本港科指今早續跌至4,224獲承接,午後高見4,342,現報4,319,倒升1.5%。
30只科指成份股逾三分二反覆造好。衆安在線(06060.HK)盈警料去年業績「見紅」轉蝕13-15億人民幣,但無阻該股跟隨其他保險同業反彈並終止四連跌,股價重越10天及250天線(22.87元及22.94元),現報23.05元,反彈8.2%。
績後獲麥格理升價44%至8.67元的聯想(00992.HK)繼上週五回吐守穩10天線,今天股價重越牛熊線,最高見7.27元,現報7.17元,回升5.8%。明源雲(00909.HK)回升4%報6.1元。
海爾智家(06690.HK)獲高盛升級至「買入」兼上調目標價33元。該股越10天及20天線,最高見30.1元,現報29.9元,回升5.3%。
特斯拉(TSLA.US)繼上週五逆標指及納指升3.1%,盤後續升0.3%報209美元。本港三大電動車股升逾3%-4%,理想汽車(02015.HK)升幅最大,最高見99.1元,現報98.85元,回升4.3%。
三大互聯網醫療股升2%-4%,其中京東健康(06618.HK)及平安好醫生(01833.HK)報60.15元及20元,分別回升近4%及3.2%。
權重新經濟股以美團(03690.HK)、網易(09999.HK)及百度(09888.HK)升幅較大,股價升逾1.5%-2.5%,後者最強曾高見145.7元。然而,瑞聲(02018.HK)及舜宇(02382.HK)逆跌逾1%-2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.